Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal Casein Kinase 1 delta Primary Antibody for IP, WB - ABIN439336
Aryal, Kwak, Tamayo, Gebert, Chiu, Walz, Weitz: Macromolecular Assemblies of the Mammalian Circadian Clock. in Molecular cell 2017
Human Polyclonal Casein Kinase 1 delta Primary Antibody for ELISA, WB - ABIN251403
Xu, Padiath, Shapiro, Jones, Wu, Saigoh, Saigoh, Ptácek, Fu: Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. in Nature 2005
Human Polyclonal Casein Kinase 1 delta Primary Antibody for IHC (p), ELISA - ABIN2477896
Babiker, Ronquist, Nilsson, Ekdahl: Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin. in The Prostate 2006
Our results reveal a new mechanism of ZNF322A (show ZNF322A Antibodies) oncoprotein destruction regulated by the CK1delta/GSK3beta/FBXW7a axis. Deregulation of this signaling axis results in ZNF322A (show ZNF322A Antibodies) overexpression and promotes cancer progression
Report temperature-compensated CKIdelta-dependent multi-site phosphorylation in mammals underlies temperature compensated phosphorylation in circadian clocks.
Study describes a specific mechanism for the regulation of CK1delta activity by proline-directed kinases, and demonstrate the relevance of this regulation in the control of a key CK1delta substrate, the PER2 (show PER2 Antibodies) protein.
Protein kinase C alpha (PKCalpha (show PKCa Antibodies)) is able to phosphorylate CK1delta at its C-terminally located residues S328, T329, and S370.
the results suggest that CK1delta activity can be modulated by the interplay between CK1delta and CDK2 (show CDK2 Antibodies)/E or CDK5 (show CDK5 Antibodies)/p35 (show ANXA1 Antibodies).
CK1delta inhibition represents a promising strategy for targeted treatment in human breast cancer with Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) involvement.
Expression of truncated hyperactive form of CKIdelta causes mislocalization and aggregation of TDP-43 (show TARDBP Antibodies) in cultured cells.
Inhibition of CK1delta increases lipid droplet formation and proliferation of both cancer and normal cells specifically under hypoxia and in an HIF-1alpha (show HIF1A Antibodies)- and lipin-1 (show LPIN1 Antibodies)-dependent manner.
site-specific phosphorylation of adiponectin, especially at sites targeted by CK1delta in vitro, provides an additional regulatory mechanism for modulating adiponectin complex formation and function.
The dynamical and conformational properties for each of three isoforms of CK1 (show CSNK1A1L Antibodies) are explored through molecular dynamics (MD) simulations.
the impact of obesity on the circadian system in mice at a behavioural and molecular level was assessed, and determined whether pharmacological targeting of casein kinase 1delta and epsilon (CK1delta/epsilon), key regulators of the circadian clock, can confer metabolic benefit.
Here, the authors identify another Wnt (show WNT2 Antibodies) signaling amplifier, CKIepsilon (show CSNK1E Antibodies), which is specifically upregulated in intestinal stem cells and is essential for intestinal stem cell maintenance, especially in the absence of its close isoform CKIdelta.
Together, these findings suggest that CK1delta contributes to the efficient repair of DNA damage and the proper functioning of mitotic checkpoints by maintaining appropriate levels of Chk1 (show CHEK1 Antibodies).
we conclude that APC (show APC Antibodies)/C(Cdh1 (show CDH1 Antibodies)) controls CK1 delta levels to balance proliferation and cell-cycle exit in the developing CNS
CK1delta mediates primary ciliogenesis by multiple mechanisms, one involving its centrosomal function and another dependent on its interaction with AKAP450 (show AKAP9 Antibodies) at the Golgi.
this article reports the crystallization and structure determination of a new crystal form of casein kinase I delta belonging to space group P21 (show D4S234E Antibodies).
decreases in CKIdelta activity can contribute to the pathogenesis of migraine.
REGgamma (show PSME3 Antibodies)-deficient mice develop premature aging phenotypes that are associated with abnormal accumulation of casein kinase (CK)1delta and p53 (show TP53 Antibodies). Antibody array analysis identified CK1delta as a direct target of REGgamma (show PSME3 Antibodies).
CK1delta plays a more prominent role than CK1epsilon (show CSNK1E Antibodies) in the maintenance of 24-hour rhythms in the master circadian oscillator
The phosphorylation of p53 (show TP53 Antibodies) by CK1 (show CSNK1A1 Antibodies) is an isoform-specific reaction to the K(221)RQK(224) loop.
The results demonstrate a high degree of evolutionary conservation of fly and vertebrate CKIdelta and of the functions affected by their period-shortening mutations.
This gene is a member of the casein kinase I (CKI) gene family whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein is highly similar to the mouse and rat CK1 delta homologs. Two transcript variants encoding different isoforms have been found for this gene.
, casein kinase I isoform delta
, tau-protein kinase CSNK1D
, casein kinase I isoform delta-B
, casein kinase I-delta
, casein kinase 1, delta
, casein kinase I, delta
, casein kinase I isoform delta-like
, casein kinase I delta
, protein kinase